Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Empowering Patients through Technology to Manage and Track Symptoms of MS
Background: Symptom management, an important component of MS care, can be achieved by using a patient app tool to manage symptoms and...
Telehealth Utilization and Clinical Outcomes in Four MS Centers during the COVID Pandemic: Real-World Evidence from the MS-Cqi Improvement Research Collaborative.
Background: MS-CQI is the first multi-center improvement research collaborative for MS care. MS-CQI was a three-year study (2018-2020) to...
Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico
Background: The incidence of multiple sclerosis (MS) in Puerto Rico (PR) is higher than in other Latin American and Caribbean countries....
Passive Monitoring of Cognition Using a Smartphone Application in MS
Background: Cognitive impairment is one of the most common and debilitating symptoms of multiple sclerosis (MS). Traditional...
Positive Outcome with Alemtuzumab in Hispanic Puerto Rican Woman with Highly Active Multiple Sclerosis after Various Failed Disease Modifying Therapies
Background: Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). It is an...